Skip to main content
. 2015 Apr 1;6(5):482–489. doi: 10.7150/jca.11665

Fig 5.

Fig 5

(A) Cumulative OS rates in patients with HCC stage I or II (n=753: 53 patients in group A, 311 in group B and 389 in group C). The difference in the three groups did not reach significance in terms of OS (P=0.103). (B) Cumulative OS rates in patients with HCC stage III or IV (n=417: 43 patients in group A, 209 in group B and 165 in group C). Significant difference was found in the three groups in terms of OS (P<0.001).